HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.

AbstractBACKGROUND:
As the number of elderly people has increased in Japan, the occurrence of aspiration pneumonia has also increased. Guidelines for the treatment of pneumonia have been proposed, in which the use of antibiotics, such as beta-lactam plus beta-lactamase inhibitor, clindamycin, and carbapenem, has been recommended as effective against anaerobic bacteria in the treatment of aspiration pneumonia. However, to our knowledge, a prospective comparison of these antibiotics regarding their clinical efficacy in aspiration pneumonia has not been performed.
STUDY OBJECTIVES:
We compared the effects of IV administration of a half dose of ampicillin/sulbactam (SBT/ABPC), normal dose of SBT/ABPC, IV clindamycin, and IV panipenem/betamiprom (PAPM/BP) for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
DESIGN:
Randomized prospective study.
PATIENTS:
One hundred adult patients with compatible signs and symptoms of aspiration pneumonia.
ASSESSMENTS:
Patients were assessed before, during, and after treatment regarding symptoms, as well as results of laboratory values, chest radiograph examinations, and sputum bacterial cultures.
RESULTS:
We found few differences between the groups regarding cure rate, duration of IV medication, and occurrence of adverse effects with the tested therapies. However, clindamycin therapy was less expensive and was associated with a lower rate of posttreatment occurrence of methicillin-resistant Staphylococcus aureus.
CONCLUSIONS:
Clindamycin therapy for mild-to-moderate aspiration pneumonia is clinically effective, and provides economic advantages as compared to SBT/ABPC or PAPM/BP therapy.
AuthorsMaiko Kadowaki, Yoshiki Demura, Shiro Mizuno, Daisuke Uesaka, Shingo Ameshima, Isamu Miyamori, Takeshi Ishizaki
JournalChest (Chest) Vol. 127 Issue 4 Pg. 1276-82 (Apr 2005) ISSN: 0012-3692 [Print] United States
PMID15821205 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Thienamycins
  • beta-Alanine
  • panipenem-betamipron
  • Clindamycin
  • sultamicillin
  • Ampicillin
  • Sulbactam
Topics
  • Aged
  • Aged, 80 and over
  • Ampicillin (administration & dosage)
  • Anti-Bacterial Agents (administration & dosage)
  • Clindamycin (administration & dosage)
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Pneumonia, Aspiration (drug therapy)
  • Prospective Studies
  • Severity of Illness Index
  • Sulbactam (administration & dosage)
  • Thienamycins (administration & dosage)
  • beta-Alanine (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: